Conference
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab
Authors
Xu B; Ma F; Ouyang Q; Li W; Jiang Z; Tong Z; Liu Y; Li H; Yu S; Feng J
Volume
78
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
February 1, 2018
Name of conference
San Antonio Breast Cancer Symposium
Conference place
TX, San Antonio
Conference start date
December 5, 2017
Conference end date
December 9, 2017
Conference proceedings
CANCER RESEARCH
Issue
4
ISSN
0008-5472